Global Molecular Diagnostics Market Report: 2013 Edition
Human
race has been persistently involved in a never ending pursuit for discovery and
innovation in every field with a special inclination towards medical sciences.
The perseverant efforts have triggered swift evolution in the realm of
diagnostic tools and techniques. In-vitro diagnostic (IVD) tests are deployed
for examining specimens including blood and tissues extracted from human body
chiefly in order to detect the presence of concerning
physiological/pathological state, or concerning congenital abnormality.
To Read The Complete Report with
TOC :-
Under
the IVD market falls the ‘Molecular Diagnostics’ sector which involves
performing analysis at the molecular level, and thereby measurement of DNA,
RNA, proteins or metabolites to detect genotypes, mutations or biochemical
changes, or to test for specific states of health or disease. Such diagnostic
methods are capable of detecting viruses, bacteria, and parasites at a fast
pace with greater sensitivity and specificity.
The
molecular diagnostics procedures for infectious diseases including HPV, CT/NG;
and the deadly gene linked cancer represent the largest market category in
terms of revenue generation. Since the realm of cancer detection and screening
procedures is undergoing a major change, the Oncology segment of the market is
poised to undergo noteworthy expansion in the near future thereby driving the molecular
diagnostics market on the holistic basis.
As
of now, the global molecular diagnostics market is characterized by growth in
large value mergers and acquisitions, personalized treatment in the field of
Oncology and reimbursement trend. While the global molecular diagnostics
marketplace remains marred by challenges like rising price pressures and
growing regulatory hurdles; the underlying growth drivers including the ever
increasing demand for better healthcare solutions, coupled with ageing world population,
reimbursement, increasing insurance density, growing demand for genetic testing
and rising new incidences of cancer, are taking the molecular diagnostics
market to new heights.
To Buy a Copy Of This Report:-
The
report analyzes the global molecular diagnostics market on a global scale and
its various segments and also provides detailed information regarding the key
umbrella markets including the diagnostics and IVD industry. It further
discusses the various industry trends, growth drivers and challenges faced by
the respective industry. In addition to the market contention prevalent in the
global molecular diagnostics market, major industry players including Roche
Holdings, Abbott Laboratories, Hologic and Novartis AG are profiled herein.
By
combining SPSS Inc.’s data integration and analysis capabilities with our
relevant findings, we have predicted the future growth of the industry. We
employed various significant variables that have an impact on this industry and
created regression models with SPSS Base to determine the future direction of
the industry. Before deploying the regression model, the relationship between
several independent or predictor variables and the dependent variable was
analyzed using standard SPSS output, including charts, tables and tests.
Contact:-
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment